Synergistic effect of the genetic polymorphisms of the renin-angiotensin- aldosterone system on high-altitude pulmonary edema: A study from Qinghai-Tibet altitude

European Journal of Epidemiology

Volumn 23, Issue 2, 2008, Pages 143-152

  Qi, Yue ^a   Niu, Wenquan ^a   Zhu, Tongchun ^b   Zhou, Wenyu ^a   Qiu, Changchun ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b China Railway Construction   (China)

Author keywords

High altitude pulmonary edema; Multifactor dimensionality reduction; Renin angiotensin aldosterone system; Synergistic effect

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; ALTITUDE DISEASE; ARTICLE; CHINA; CONTROLLED STUDY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; LINKAGE ANALYSIS; LUNG EDEMA; MAJOR CLINICAL STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UREA NITROGEN BLOOD LEVEL; X CHROMOSOME;

ADULT; ALDOSTERONE SYNTHASE; ALTITUDE SICKNESS; CASE-CONTROL STUDIES; CHINA; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY EDEMA; RENIN-ANGIOTENSIN SYSTEM; TIBET;

EID: 38649139357     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-007-9208-0     Document Type: Article

References (40)

1. Bartsch P, Mairbaurl H, Maggiorini M, Swenson ER. Physiological aspects of high-altitude pulmonary edema. J Appl Physiol 2005;98:1101-10.
2. Maggiorini M, Leon-Velarde F. High-altitude pulmonary hypertension: a pathophysiological entity to different diseases. Eur Respir J 2003;22:1019-25.
3. Mortimer H, Patel S, Peacock AJ. The genetic basis of high-altitude pulmonary oedema. Pharmacol Ther 2004;101:183-92.
4. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003;56:73-82.
5. Moore JH, Williams SM. Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis. Bioessays 2005;27:637-46.
6. Hultgren HN, Grover RF, Hartley LH. Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation 1971;44:759-70.
7. Eldridge MW, Podolsky A, Richardson RS, Johnson DH, Knight DR, Johnson EC, Hopkins SR, Michimata H, Grassi B, Feiner J, Kurdak SS, Bickler PE, Wagner PD, Severinghaus JW. Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edema. J Appl Physiol 1996;81:911-21.
8. Basnyat B, Murdoch DR. High-altitude illness. Lancet 2003;361:1967-74.
9. Hotta J, Hanaoka M, Droma Y, Droma Y, Katsuyama Y, Ota M, Kobayashi T. Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest 2004;126:825-30.
10. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, Hayward M, Holliman DE, Jubb M, World M, Thomas EL, Brynes AE, Saeed N, Barnard M, Bell JD, Prasad K, Rayson M, Talmud PJ, Humphries SE. Human gene for physical performance. Nature 1998;393:221-2.
11. Woods DR, Montgomery HE. Angiotensin-converting enzyme and genetics at high altitude. High Alt Med Biol 2001;2:201-10.
12. Qadar Pasha MA, Khan AP, Kumar R, Grover SK, Ram RB, Norboo T, Srivastava KK, Selvamurthy W, Brahmachari SK. Angiotensin converting enzyme insertion allele in relation to high altitude adaptation. Ann Hum Genet 2001;65:531-6.
13. Woods DR, Pollard AJ, Collier DJ, Jamshidi Y, Vassiliou V, Hawe E, Humphries SE, Montgomery HE. Insertion/deletionpolymorphism of the angiotensin I-converting enzyme gene and artery oxygen saturation at high altitude. Am J Respir Crit Care Med 2002;166:362-6.
14. Keynes RJ, Smith GW, Slater JD, Brown MM, Brown SE, Payne NN, Jowett TP, Monge CC. Renin and aldosterone at high altitude in man. J Endocrinol 1982;92:131-40.
15. Morrell NW, Morris KG, Stenmark KR. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxia pulmonary hypertension. Am J Physiol 1995;269:H1186-94.
16. Kumar R, Pasha Q, Khan AP, Gupta V. Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema. Aviat Space Environ Med 2004;75:981-3.
17. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002;34:88-95.
18. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138-47.
19. Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003;24:150-7.
20. Hahn LW, Moore JH. Ideal discrimination of discrete clinical endpoints using multilocus genotypes. In Silico Biol 2004;4:183-94.
21. Moore JH. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 2004;4:795-803.
22. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, White BC. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006;241:252-61.
23. Martin ER, Ritchie MD, Hahn L, Kang S, Moore JH. A novel method to identify gene-gene effects in nuclear families: the MDR-PDT. Genet Epidemiol 2006;30:111-23.
24. Millstein J, Conti DV, Gilliland FD, Gauderman WJ. A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet 2006;78:15-27.
25. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, Tosteson TD, Schned AR, Karagas MR. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 2006;27:1030-7.
26. Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Watanabe T, Moore JH, Ritchie MD, Williams SM, Pezzullo JC, Sasaki M, Eisner GM, Jose PA, Felder RA. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem 2006;52:352-60.
27. Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL, Cree BA, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD. Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun 2006;7:310-5.
28. Cho YM, Ritchie MD, Moore JH, Park JY, Lee KU, Shin HD, Lee HK, Park KS. Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus. Diabetologia 2004;47:549-54.
29. Zapata C, Carollo C, Rodriguez S. Sampling variance and distribution of the D' measure of overall gametic disequilibrium between multiallelic loci. Ann Hum Genet 2001;65:395-406.
30. Moore JH, White BC. Tuning ReliefF for genome-wide genetic analysis. Lect Notes Comput Sci 2007;4447:166-75.
31. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003;19:376-82.
32. The International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-96.
33. Moore JH, Ritchie MD. The challenges of whole-genome approaches to common diseases. JAMA 2004;291:1642-3.
34. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD, Moore JH, Hsu KL, Tseng CD, Liau CS, Tseng YZ. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004;109:1640-6.
35. Frankel WN, Schork NJ. Who's afraid of epistasis? Nat Genet 1996;14:371-3.
36. Erdos EG. Conversion of angiotensin I to angiotensin II. Am J Med 1976;60:749-59.
37. Cargill RI, Lipworth BJ. Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest 1996;109:424-9.
38. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol 1997;11:638-49.
39. Hackett PH, Rennie D, Hofmeister SE, Grover RF, Grover EB, Reeves JT. Fluid retention and relative hypoventilation in acute mountain sickness. Respiration 1982;43:321-9.
40. Cox NJ, Bell GI. Disease associations. Chance, artifact, or susceptibility genes. Diabetes 1989;38:947-50.